SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Ayurcann Holdings Corp. (AYURF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 20/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AYURF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.05
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.01
Book Value / Share$0.00
Revenue / Share$0.16
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.03 |
$0.00 |
$-313.61K |
- |
| 2017 |
$-0.02 |
$0.00 |
$-199.84K |
- |
| 2018 |
$-0.02 |
$0.00 |
$-272.77K |
- |
| 2019 |
$-0.01 |
$0.00 |
$-222.82K |
- |
| 2020 |
$-0.01 |
$0.00 |
$-236.94K |
- |
| 2021 |
$0.00 |
$7.63M |
$-278.36K |
-3.6% |
| 2022 |
$-0.03 |
$9.39M |
$-3.09M |
-32.9% |
| 2023 |
$-0.04 |
$12.49M |
$-5.31M |
-42.5% |
| 2024 |
$-0.02 |
$25.16M |
$-3.97M |
-15.8% |
| 2025 |
$-0.01 |
$31.11M |
$-3.49M |
-11.2% |
